New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4782-4791

  Geluk, Annemieke ^a   Bobosha, Kidist ^a,b   Van Der Ploeg van Schip, Jolien J ^a   Spencer, John S ^c   Banu, Sayera ^d   Martins, Marcia V S B ^e   Cho, Sang Nae ^f   Franken, Kees L M C ^f   Kim, Hee Jin ^g   Bekele, Yonas ^b   Uddin, Mohammad K M ^d   Hadi, Sheikh Abdul ^d   Aseffa, Abraham ^b   Pessolani, Maria C V ^e   Pereira, Geraldo M B ^g   Dockrell, Hazel M ^h   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f Yonsei University College of Medicine   (South Korea)

^g STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BIOLOGICAL MARKER; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

AREA UNDER THE CURVE; ARTICLE; BANGLADESH; BRAZIL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DIAGNOSTIC ACCURACY; DISEASE MARKER; ETHIOPIA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEPROSY; MYCOBACTERIUM LEPRAE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SOUTH KOREA; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, BACTERIAL; BANGLADESH; BIOLOGICAL MARKERS; BRAZIL; CYTOKINES; ETHIOPIA; FEMALE; HUMANS; INTERFERON-GAMMA; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; REPUBLIC OF KOREA; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 84861122390     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103452     Document Type: Article

References (45)

1. Leprosy update, 2011. Wkly. Epidemiol. Rec. 86: 389-399.
2. Oskam, L., E. Slim, and S. Bührer-Sékula. 2003. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr. Rev. 74: 196-205. (Pubitemid 37205454)
3. Maeda, S. M., O. Rotta, N. S. Michalany, Z. P. Camargo, C. Sunderkötter, and J. Tomimori-Yamashita. 2003. Comparison between anti-PGL-I serology and Mitsuda reaction: clinical reading, microscopic findings and immunohistochemical analysis. Lepr. Rev. 74: 263-274. (Pubitemid 37205462)
4. Roberts, P. P., H. M. Dockrell, and K. P. McAdam. 1988. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis. Clin. Exp. Immunol. 72: 390-393.
5. Burki, T. 2010. Fight against leprosy no longer about the numbers. Lancet Infect. Dis. 10: 74.
6. Cole, S. T., K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Wheeler, N. Honoré, T. Garnier, C. Churcher, D. Harris, et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409: 1007-1011. (Pubitemid 32204045)
7. Aráoz, R., N. Honoré, S. Banu, C. Demangel, Y. Cissoko, C. Arama, M. K. Uddin, S. K. Hadi, M. Monot, S. N. Cho, et al. 2006. Towards an immunodiagnostic test for leprosy. Microbes Infect. 8: 2270-2276. (Pubitemid 44322057)
8. Dockrell, H. M., S. Brahmbhatt, B. D. Robertson, S. Britton, U. Fruth, N. Gebre, M. Hunegnaw, R. Hussain, R. Manandhar, L. Murillo, et al. 2000. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect. Immun. 68: 5846-5855.
9. Geluk, A., M. R. Klein, K. L. Franken, K. E. van Meijgaarden, B. Wieles, K. C. Pereira, S. Bührer-Sékula, P. R. Klatser, P. J. Brennan, J. S. Spencer, et al.c 2005. Postgenomic approach to identify novel Mycobacteriumleprae antigenswith potential to improve immunodiagnosis of infection. Infect. Immun. 73: 5636-5644.
10. Geluk, A., J. S. Spencer, K. Bobosha, M. C. Pessolani, G. M. Pereira, S. Banu, N. Honoré, S. T. Reece, M. MacDonald, B. R. Sapkota, et al.; IDEAL Consortium. 2009. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin. Vaccine Immunol. 16: 352-359.
11. Sampaio, L. H., M. M. Stefani, R. M. Oliveira, A. L. Sousa, G. C. Ireton, S. G. Reed, and M. S. Duthie. 2011. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect. Dis. 11: 26.
12. Spencer, J. S., H. M. Dockrell, H. J. Kim, M. A. Marques, D. L. Williams, M. V. Martins, M. L. Martins, M. C. Lima, E. N. Sarno, G. M. Pereira, et al. 2005. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J. Immunol. 175: 7930-7938. (Pubitemid 41798353)
13. Wallis, R. S., M. Pai, D. Menzies, T. M. Doherty, G. Walzl, M. D. Perkins, and A. Zumla. 2010. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.
14. Franken, K. L., H. S. Hiemstra, K. E. van Meijgaarden, Y. Subronto, J. den Hartigh, T. H. Ottenhoff, and J. W. Drijfhout. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr. Purif. 18: 95-99. (Pubitemid 30097778)
15. Ridley, D. S., and W. H. Jopling. 1966. Classification of leprosy according to immunity: a five-group system. Int. J. Lepr. Other Mycobact. Dis. 34: 255-273.
16. Geluk, A., J. van der Ploeg, R. O. Teles, K. L. Franken, C. Prins, J. W. Drijfhout, E. N. Sarno, E. P. Sampaio, and T. H. Ottenhoff. 2008. Rational combination of peptides derived from different Mycobacteriumleprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Clin. Vaccine Immunol. 15: 522-533. (Pubitemid 351967078)
17. Geluk, A., J. J. van der Ploeg-van Schip, K. E. van Meijgaarden, S. Commandeur, J. W. Drijfhout, W. E. Benckhuijsen, K. L. Franken, B. Naafs, and T. H. Ottenhoff. 2010. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays. Clin. Vaccine Immunol. 17: 993-1004.
18. Bobosha, K., J. J. van der Ploeg-van Schip, D. A. Esquenazi, M. M. Guimarães, M. V. Martins, Y. Bekele, Y. Fantahun, A. Aseffa, K. L. Franken, R. C. Gismondi, et al. 2012. Peptides derived from Mycobacterium leprae ML1601c discriminate between leprosy patients and healthy endemic controls. J. Trop. Med. 2012: 132049.
19. Spencer, J. S., H. J. Kim,W. H. Wheat, D. Chatterjee, M.V. Balagon, R.V. Cellona, E.V. Tan, R. Gelber, P. Saunderson,M. S. Duthie, et al.; IDEAL Consortium. 2011. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin. Vaccine Immunol. 18: 260-267.
20. Chegou, N. N., G. F. Black, M. Kidd, P. D. van Helden, and G. Walzl. 2009. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med. 9: 21.
21. Ruhwald, M., J. Dominguez, I. Latorre, M. Losi, L. Richeldi, M. B. Pasticci, R. Mazzolla, D. Goletti, O. Butera, J. Bruchfeld, et al.; TBNET. 2011. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis 91: 260-267.
22. Ellner, J. J. 2010. Immunoregulation in TB: observations and implications. Clin. Transl. Sci. 3: 23-28.
23. Hirsch, C. S., Z. Toossi, C. Othieno, J. L. Johnson, S. K. Schwander, S. Robertson, R. S. Wallis, K. Edmonds, A. Okwera, R. Mugerwa, et al. 1999. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180: 2069-2073.
24. Hussain, R., A. Kaleem, F. Shahid, M. Dojki, B. Jamil, H. Mehmood, G. Dawood, and H. M. Dockrell. 2002. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J. Immunol. Methods 264: 95-108. (Pubitemid 34615896)
25. Sahiratmadja, E., B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. Nelwan, S. Marzuki, J. W. van der Meer, R. van Crevel, et al. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75: 820-829. (Pubitemid 46203445)
26. Rodrigues, L. C., and D. Nj. Lockwood. 2011. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect. Dis. 11: 464-470.
27. Scollard, D. M., L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams. 2006. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19: 338-381.
28. Pai, M., L. W. Riley, and J. M. Colford, Jr. 2004. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect.Dis. 4: 761-776.
29. Rangaka, M. X., K. A. Wilkinson, J. R. Glynn, D. Ling, D. Menzies, J. Mwansa- Kambafwile, K. Fielding, R. J. Wilkinson, and M. Pai. 2012. Predictive value of interferon-g release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 12: 45-55.
30. Hatta, M., S. M. van Beers, B. Madjid, A. Djumadi, M. Y. de Wit, and P. R. Klatser. 1995. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 89: 381-385.
31. Ruhwald, M., M. Bjerregaard-Andersen, P. Rabna, J. Eugen-Olsen, and P. Ravn. 2009. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes 2: 19.
32. Aabye, M. G., M. Ruhwald, G. Praygod, K. Jeremiah, M. Faurholt-Jepsen, D. Faurholt-Jepsen, N. Range, H. Friis, J. Changalucha, A. B. Andersen, and P. Ravn. 2010. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur. Respir. J. 36: 1488-1490.
33. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lmphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652-3656. (Pubitemid 24139489)
34. Hussain, R., A. Ansari, N. Talat, Z. Hasan, and G. Dawood. 2011. CCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infection. PLoS One 6: e25803.
35. Hasan, Z., J. M. Cliff, H. M. Dockrell, B. Jamil, M. Irfan, M. Ashraf, and R. Hussain. 2009. CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One 4: e8459.
36. Hasan, Z., B. Jamil, I. Zaidi, S. Zafar, A. A. Khan, and R. Hussain. 2006. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy. Scand. J. Immunol. 63: 241-247. (Pubitemid 43356786)
37. Joosten, S. A., K. E. van Meijgaarden, N. D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. Ottenhoff. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104: 8029-8034. (Pubitemid 47185870)
38. Mayer-Barber, K. D., D. L. Barber, K. Shenderov, S. D. White, M. S. Wilson, A. Cheever, D. Kugler, S. Hieny, P. Caspar, G. Núñez, et al. 2010. Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184: 3326-3330 .
39. Liu, P. T., M. Wheelwright, R. Teles, E. Komisopoulou, K. Edfeldt, B. Ferguson, M. D. Mehta, A. Vazirnia, T. H. Rea, E. N. Sarno, et al. 2012. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat. Med. 18: 267-273.
40. Kurtz, J. 2005. Specific memory within innate immune systems. Trends Immunol. 26: 186-192. (Pubitemid 41556855)
41. Lima, M. C., G. M. Pereira, F. D. Rumjanek, H. M. Gomes, N. Duppre, E. P. Sampaio, I. M. Alvim, J. A. Nery, E. N. Sarno, and M. C. Pessolani. 2000. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scand. J. Immunol. 51: 419-428. (Pubitemid 30212286)
42. Misra, N., M. Selvakumar, S. Singh, M. Bharadwaj, V. Ramesh, R. S. Misra, and I. Nath. 1995. Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy. Immunol. Lett. 48: 123-128. (Pubitemid 26014798)
43. Burl, S., U. J. Adetifa, M. Cox, E. Touray, H. Whittle, H. McShane, S. L. Rowland-Jones, and K. L. Flanagan. 2010. The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One 5: e12287.
44. Corstjens, P. L., C. J. de Dood, J. J. van der Ploeg-van Schip, K. C. Wiesmeijer, T. Riuttamäki, K. E. van Meijgaarden, J. S. Spencer, H. J. Tanke, T. H. Ottenhoff, and A. Geluk. 2011. Lateral flow assay for simultaneous detection of cellularand humoral immune responses. Clin. Biochem. 44: 1241-1246.
45. Corstjens, P. L., M. Zuiderwijk, H. J. Tanke, J. J. van der Ploeg-van Schip, T. H. Ottenhoff, and A. Geluk. 2008. A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells. Clin. Biochem. 41: 440-444.